Sir, In general, we agree with the comments by Drs Wernig related to our recent publication (Kubasak et al., 2008) that reported improved locomotor function after olfactory ensheathing glia (OEG) implantation. We, however, would like to expand upon several points. If future rodent studies of implanted OEG combined with step training also report locomotor recovery after a complete spinal cord transection and if this improvement is demonstrated to be due primarily to axon regeneration across the injury site, then rigorously testing the potential of OEG transplantation combined with step training in humans should be considered. Certainly the delay between injury and OEG implantation would be an important issue to consider, in addition to the use of centrally rather than peripherally derived OEG. Based on primate (Rubio et al., 2008) and human studies (Mackay-Sim et al., 2008) , autologous OEG could be generated within a period of 1-2 months. Furthermore, we have preliminary results demonstrating that olfactory bulb OEG transplantation into completely transected rats can be delayed for up to 4 months without any decay in efficacy ( Drs Wernig also are correct in pointing out that it is difficult to determine which factors can be attributed to 'voluntary' control using animal models. Despite the fact that we found evidence of serotonergic axon growth across the transection site in rats, we cannot assume that these axons would mediate voluntary control. A second possibility is that the improved locomotor performance could be attributed primarily to changes in the spinal circuits associated with locomotion that are intrinsic to the lumbosacral spinal cord (Edgerton et al., 2004) . Our current experiments are designed to determine whether axonal regeneration across a complete spinal cord transection and/or intrinsic reorganization of the lumbosacral locomotor circuits are involved in the functional improvement observed after OEG transplantation. 
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